Advanced search
Publication Cover
Expert Opinion on Therapeutic Patents Volume 14, 2004 - Issue 5
Submit an article Journal homepage
24
Views
0
CrossRef citations to date
0
Altmetric
Review

β-Cell regeneration: a potential cure for Type 1 diabetes

Michael D Kulis Jr Georgia Institute of Technology, Institute for Bioengineering and Bioscience, 315 Ferst Drive, Atlanta GA 30332, USA. [email protected]
&
Suzanne B Shuker Georgia Institute of Technology, Institute for Bioengineering and Bioscience, 315 Ferst Drive, Atlanta GA 30332, USA. [email protected]
Pages 599-605 | Published online: 02 Mar 2005

Bibliography

  • MOUSTAKAS A, PAPADOPOULOS G: Molecular properties of HLA-DQ alleles conferring susceptibility to or protection from insulin-dependent diabetes mellitus: keys to the fate of islet 0-cells. Amer . j Med. Genetics (2002) 115:37–47.
  • NOTKINS A: Immunologic and genetic factors in Type 1 diabetes. Bio. Chem. (2002) 277:43545–43548.
  • AKERBLOM H, VAARALA 0, HYOTY H, ILONEN J, KNIP M: Environmental factors in the aetiology of Type 1 diabetes. Amer. j Med. Genetics (2002) 115:18–29.
  • SCHWARTZ S, BORNFELDT K: How does diabetes accelerate atherosclerotic plaque rupture and arterial occlusion? Front. Biosci. (2003) 8:1371–1383.
  • SHAPIRO A, LAKEY J, RYAN E et al.: Islet transplantation in seven patients with Type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl. I Med. (2000) 343:230–238.
  • YAMAOKA T: Regeneration therapy for diabetes mellitus. Expert Opin. Biol. Ther. (2003) 3:425–433.
  • ROSENBERG L: In vivo cell transformation : neogenesis of fl cells from pancreatic ductal cells. Cell Transplant. (1995) 4:371–383.
  • •Historical overview of 13-cell neogenesis with specific models of in vivo differentiation.
  • SUMI S, TAMURA K: Frontiers of pancreas regeneration. Hepatobiliary Pancreat. Sorg. (2000) 7:286–294.
  • •Various transcription and growth factors are discussed.
  • NIELSEN J, SVENSSON C, GALSGAARD E, MOULDRUP A, BILLESTRUP N: f3 Cell proliferation and growth factors. Mol Med. (1999) 77:62–66.
  • RISBUD M, BHONDE R: Models of pancreatic regeneration in diabetes. Diabetes Rsch. Clin. Prac. (2002) 58:155–165.
  • •Reviews the models used to study pancreatic regeneration.
  • YAMAOKA T: Gene therapy for diabetesmellitus. Carr: Ma Med. (2001) 1:325–337.
  • MICHAELS MG: Xenotransplant-associated infections. Lab. Amin. Sci. (1998) 48:228–233.
  • YAMAOKA T, YOSHINO K, YAMADA T et al.: Diabetes and tumour formation in transgenic mice expressing Reg I. Biochem. Biophys. Rsch. Comm. (2000) 278:368–376.
  • BOUVVENS L: Transdifferentiation versus stem cell hypothesis for the regeneration of islet 0-cells in the pancreas. Microscopy Rsch. Tech. (1998) 43:332–336.
  • EDLUND H: Transcribing pancreas. Diabetes (1998) 47:1817–1823.
  • HEREMANS Y, VAN DE CASTEELE M, IN'T VELD P et al.: Recapitulation of embryonic neuroendocrine differentiation in adult human pancreatic duct cells expressing neurogenin 3.1 Cell Biol. (2002) 159:303–312.
  • GREY D: Encapsulated islet cells: the role of direct and indirect presentation and the relevance to xenotransplantation and autoimmune recurrence. Br. Med. Bull. (1997) 53:777–788.
  • MARIA-ENGLER S, MARES-GUIA M, CORREA M et al.: Microencapsulation and tissue engineering as an alternative treatment of diabetes. Braz. .1 Med. Biol. Res. (2001) 34:691–697.
  • KAUFMAN D, LOWE W: Clinical islet transplantation. Carr. Diab. Rep. (2003) 3:344–350.
  • COTTERELL A, KENYON N: Alternatives to immunosuppressive drugs in human islet transplantation. Carr. Diab. Rep. (2002) 2:377–382.
  • •Possible substitutes for immunosuppressive therapy following islet transplantation are discussed.
  • RAY M, FAGAN S, BRUNICARDI F: The Cre-loxP system: a versatile tool for targeting genes in a cell and stage-specific manner. Cell Transplant. (2000) 9:805–815.
  • WATANABE T, YONEMURA Y, YONEKURA H et al.: Pancreatic 0-cell replication and amelioration of surgical diabetes by Reg protein. Proc. Natl. Acad. Sci. USA (1994) 91:3589–3592.
  • TAKASAWA S, OKAMOTO H: Pancreatic 0-cell death, regeneration and insulin secretion: roles of poly (ADP-ribose) polymerase and cyclic ADP-ribose. Int. J. Exp. Diabetes Res. (2002) 3:79–96.
  • FENJVES E, RICORDI C: Gene therapy for Type 1 diabetes. Expert Opin. Ther. Patents (2000) 10:325–331.
  • YOON J, JUN H: Recent advances in insulin gene therapy for Type 1 diabetes. Trends Mol Med. (2002) 8:62–68.
  • XU R, LI H, TSE L, KUNG H, LU H, LAM K: Diabetes gene therapy: potential and challenges. Carr: Gene Ther: (2003) 3:65–82.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.